Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Switzerland"

140 News Found

Thermo Fisher opens biologics site in Lengnau, Switzerland
News | October 04, 2021

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production


Lonza to expand its drug manufacturing network in Switzerland
Biotech | September 23, 2021

Lonza to expand its drug manufacturing network in Switzerland

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland


Roche inaugurates new research home for the Institute of Human Biology
R&D | March 24, 2026

Roche inaugurates new research home for the Institute of Human Biology

The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients


Strides acquires generic brands from Sandoz to boost Africa business
News | March 19, 2026

Strides acquires generic brands from Sandoz to boost Africa business

The initial consideration for the transaction is US$ 12 million


Veristat expands global trial & regulatory services as Chinese drugmakers push overseas
Clinical Trials | March 14, 2026

Veristat expands global trial & regulatory services as Chinese drugmakers push overseas

The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals


STADA & Bio-Thera bag European nod for Gotenfia
Drug Approval | February 16, 2026

STADA & Bio-Thera bag European nod for Gotenfia


Singapore clears AI bladder cancer detection tool
News | January 06, 2026

Singapore clears AI bladder cancer detection tool

CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes


Astal signs LoI with Immuna Therapeutics
News | December 30, 2025

Astal signs LoI with Immuna Therapeutics

Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation


CPHI & PMEC India 2025 ignites pharma innovation and partnerships
News | December 29, 2025

CPHI & PMEC India 2025 ignites pharma innovation and partnerships

For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows